TwinPharma contributes to improve the health care in the Netherlands, Belgium and Luxembourg.
We do this by introducing added value medicines that up to now were not available in these countries.

Hepatect CP

Hepatect CP contains mainly IgG with a specifically high content of antibodies against hepatitis B virus surface antigen.

hepatec

Megalotect 100 E/ml

Megalotect 100 E/ml is an immunoglobulin preparation from plasma of donors with a high antibody titer against the cytomegalovirus.

megalotect

Zutectra

Prevention of hepatitis B virus re-infection in HBsAg and HBV-DNA negative adult patients at least one week after liver transplantation for hepatitis B induced liver failure.

zutectra

Interim & advice

Open positions, replacement or extra activities? TwinPharma can offer a solution.

Welcome to TwinPharma!

We have created this site to make it easier for you to get in touch with you. For a first acquaintance, to get an idea of our medicines or to share with you our philosophy and the way we work. Be welcome and look around. We appreciate your response and hope to speak to you personally as soon as possible.

Sincerely,

Bauke Buwalda and Gert van Alewijk

Email: info@twinpharma.com

Are you looking for a distributor of medicines in Europe?

TwinPharma and Anthrop Pharmaceuticals have joined forces and reach out to more that 50 million Europeans in 7 countries

50me-logo

Local Dutch-Belgian full service consultancy market access chain

Achieving reimbursement and price are the 2 most important drivers for a successful launch of an innovative medicine in the Netherlands and Belgium.
TwinPharma is working in a network with specialised partners in market access, pricing, pharmaco-economics, regulatory and KOL-management in the Netherlands and Belgium.